Onconetix, Inc. (ONCO)
0.6547
0.00 (0.00%)
USD |
NASDAQ |
Aug 25, 16:00
0.643
-0.01
(-1.79%)
After-Hours: 18:11
Onconetix Total Liabilities (Quarterly) : 2.956M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.956M |
| March 31, 2026 | 3.084M |
| December 31, 2025 | 9.171M |
| September 30, 2025 | 16.30M |
| June 30, 2025 | 12.77M |
| March 31, 2025 | 14.26M |
| December 31, 2024 | 18.60M |
| September 30, 2024 | 20.90M |
| June 30, 2024 | 23.96M |
| March 31, 2024 | 25.29M |
| December 31, 2023 | 23.18M |
| September 30, 2023 | 17.65M |
| Date | Value |
|---|---|
| June 30, 2023 | 16.67M |
| March 31, 2023 | 2.809M |
| December 31, 2022 | 3.922M |
| September 30, 2022 | 4.431M |
| June 30, 2022 | 3.059M |
| March 31, 2022 | 2.801M |
| December 31, 2021 | 1.638M |
| September 30, 2021 | 0.796M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 0.0783M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Aprea Therapeutics, Inc. | 3.092M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.43M |
| Shareholders Equity (Quarterly) | 13.47M |
| Debt to Equity Ratio | 0.0139 |
| Current Ratio | 2.214 |
| Net Debt Paydown Yield | 45.08% |